Richards Packaging Inc. v. Distrimedic Inc.
Prothonotary Steele's ruling was correct: s.16.1 of the Patent Act protects the challenged communications retroactively except for disclosure required in proceedings that were ongoing on June 24, 2016; Richards did not waive privilege beyond the limited material actually disclosed to the Patent Office; Distrimedic failed to adduce prima facie evidence of fraud or other serious unlawful purpose that would defeat solicitor‑client or patent‑agent privilege; the Rule 237(4) examination transcript was inadmissible for the purposes advanced and would not alter the outcome, therefore the appeal is dismissed.
- Citation
- 2020 FC 1162
- Parties
- Plaintiff / Defendant by Counterclaim: Richards Packaging Inc.; Defendant / Plaintiff by Counterclaim: Distrimedic Inc.
- Court
- Federal Court
- Jurisdiction
- Canada
- Judgment Date
- 17 December 2020
- Procedural Posture
- Patent Infringement and Reissue Validity Dispute / Appeal of Prothonotary Steele's Privilege Order (motion Under Rule 51)
- Outcome
- Appeal dismissed; Privilege Order of Prothonotary Steele dated February 10, 2020 affirmed
- Legal Topics
- Reissue Under S.47 Patent Act, Section 16.1 Patent Act Retroactivity, Waiver/implied Waiver of Privilege, Fraud/misconduct Exception to Privilege, Admission of New Evidence on Appeal, Rule 237(4) Examinations
- Source Language
- English
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Richards Packaging Inc.
Plaintiff / Defendant by Counterclaim
Distrimedic Inc.
Defendant / Plaintiff by Counterclaim
Procedural Posture
Patent Infringement and Reissue Validity Dispute / Appeal of Prothonotary Steele's Privilege Order (motion Under Rule 51)
Legal Issues
- 1 Whether s.16.1(6) of the Patent Act bars retroactive patent‑agent privilege for communications that predate June 24, 2016 and relate to proceedings commenced before that date
- 2 Whether Richards waived privilege (expressly or impliedly) by disclosing redacted communications to the Patent Office during the reissue process and by putting instructions to patent agents in issue
- 3 Whether alleged misconduct (improper purpose to capture competitor) defeats solicitor‑client or patent‑agent privilege and whether Distrimedic established a prima facie case of fraud
Ratio Decidendi
Prothonotary Steele's ruling was correct: s.16.1 of the Patent Act protects the challenged communications retroactively except for disclosure required in proceedings that were ongoing on June 24, 2016; Richards did not waive privilege beyond the limited material actually disclosed to the Patent Office; Distrimedic failed to adduce prima facie evidence of fraud or other serious unlawful purpose that would defeat solicitor‑client or patent‑agent privilege; the Rule 237(4) examination transcript was inadmissible for the purposes advanced and would not alter the outcome, therefore the appeal is dismissed.
Court Disposition
Appeal dismissed; Privilege Order of Prothonotary Steele dated February 10, 2020 affirmed
Orders
- The appeal by Distrimedic Inc. is dismissed.
- Costs awarded to Richards Packaging Inc. in the aggregate lump sum of $6,000.00, including taxes and disbursements.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment